We are live on ! Find out more
ACIU icon

AC Immune
ACIU

41 hedge funds and large institutions have $90.6M invested in AC Immune in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 6

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

5% more funds holding

Funds holding: 39 → 41 (+2)

3.52% less ownership

Funds ownership: 30.06% → 26.54% (-3.5%)

53% less capital invested

Capital invested by funds: $191M → $90.6M (-$101M)

Holders
41
Holders Change
+2
Holders Change %
+5.13%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
14
Reduced
6
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$33.2M
2
PM
Prosight Management
Texas
+$4.52M
3
AG
Artal Group
Luxembourg
+$1.59M
4
Artisan Partners
Artisan Partners
Wisconsin
+$1.14M
5
Millennium Management
Millennium Management
New York
+$1.08M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$22.4M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$14.9M
3
O
OrbiMed
New York
-$13.6M
4
DFO
Duquesne Family Office
New York
-$7.42M
5
Marshall Wace
Marshall Wace
United Kingdom
-$4.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$164K -$6.23K -979 -3%
Goldman Sachs
27
Goldman Sachs
New York
$164K +$34K +5,338 +20%
Marshall Wace
28
Marshall Wace
United Kingdom
$143K -$4.5M -707,555 -96%
ProShare Advisors
29
ProShare Advisors
Maryland
$116K +$22.1K +3,473 +18%
SIM
30
Spark Investment Management
New York
$115K +$146K +22,900 New
MWNA
31
Marshall Wace North America
New York
$80K +$86.8K +13,654 +626%
CS
32
Credit Suisse
Switzerland
$80K +$100K +15,768 New
JP Morgan Chase
33
JP Morgan Chase
New York
$76K +$95.7K +15,049 New
LBC
34
Lawrence B. Cohen
$67K – – –
Jane Street
35
Jane Street
New York
$56K +$70.7K +11,116 New
TRCT
36
Tower Research Capital (TRC)
New York
$41K +$51.9K +8,164 New
UBS Group
37
UBS Group
Switzerland
$21K +$20.9K +3,283 +398%
Citigroup
38
Citigroup
New York
$5K +$6.15K +967 New
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$2K +$2.73K +430 New
Janus Henderson Group
40
Janus Henderson Group
United Kingdom
– -$14.9M -1,578,814 Closed
O
41
OrbiMed
New York
– -$13.6M -1,440,000 Closed
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
– -$3.58M -378,700 Closed
SFM
43
Sphera Funds Management
Israel
– -$2.94M -310,613 Closed
Balyasny Asset Management
44
Balyasny Asset Management
Illinois
– -$1.04M -110,000 Closed
TI
45
Trexquant Investment
Connecticut
– -$468K -49,544 Closed
EIM
46
Essex Investment Management
Massachusetts
– -$359K -37,968 Closed
OAM
47
Oxford Asset Management
United Kingdom
– -$216K -22,847 Closed
PCM
48
Prelude Capital Management
New York
– -$184K -19,515 Closed
TD Asset Management
49
TD Asset Management
Ontario, Canada
– -$165K -17,506 Closed
Squarepoint
50
Squarepoint
New York
– -$121K -12,800 Closed
1
2
3

ACIU Hedge Fund Activity: Q1 2019 in Review

41 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q1 2019, worth a combined $90.6M — down 53% from $191M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ACIU positions and 14 closed out — a net gain of 2 holders — while 14 added to existing stakes and 6 trimmed.

The largest buyer was BVF Inc, adding an estimated $33.2M. The largest seller was Fidelity Investments, cutting an estimated $22.4M.

  • 41 institutional investors held AC Immune (ACIU) as of Q1 2019, up from 39 in Q4 2018.
  • Funds reported $90.6M of AC Immune stock for Q1 2019, down 53% quarter-over-quarter.
  • 16 funds opened new AC Immune positions in Q1 2019 and 14 closed out, a net change of +2 holders.
  • The largest AC Immune buyer in Q1 2019 was BVF Inc, an estimated $33.2M added.
  • The largest AC Immune seller in Q1 2019 was Fidelity Investments, an estimated $22.4M sold.

Based on aggregated 13F filings for Q1 2019.